clinical trial · NCT05939128
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
Breast Cancer
brief summary
(Neo)adjuvant treatment approaches and outcomes
started
Jun 30, 2023
primary completion
Sep 30, 2027
completion
Sep 30, 2027
last updated
Oct 2, 2026
official title
A Multicentre, Single Arm, Non-interventional, Observational, Prospective Study to Assess the BRCA1/2m Prevalence, Treatment Approaches and Outcomes in HER2-negative High-risk Early Breast Cancer Patients in Russia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol